Physician Assistant, Medical · Beverly Hills, CA
NPI
1700404357
Since 2020
Specialty
Physician Assistant, Medical
Code 363AM0700X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
8750 Wilshire Blvd Ste 210
Beverly Hills, CA, 90211
Phone (310) 652-0920
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$1.2M
1,209 prescriptions
Company payments, 2025
$4,289
From 19 companies
Medicare prescription drug claims, 2024
In 2024, the drug Ashley N Banayan prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 147 prescriptions and refills. In total Ashley N Banayan wrote 1,209 Medicare prescriptions that cost $1.2M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-05-22.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Hydroxychloroquine Sulfate Generic | 147 | 280 | 49 | $5,180 |
| Methotrexate Methotrexate Sodium | 129 | 206 | 32 | $3,457 |
| Prednisone Generic | 109 | 158 | 37 | $660 |
| Gabapentin Generic | 70 | 127 | 27 | $974 |
| Leflunomide Generic | 48 | 88 | 21 | $3,061 |
| Xeljanz Xr Tofacitinib Citrate | 43 | 43 | Under 11 | $243K |
| Pilocarpine Hcl Generic | 40 | 60 | 12 | $2,317 |
| Duloxetine Hcl Generic | 35 | 67 | 11 | $689 |
| Methylprednisolone Generic | 34 | 34 | 27 | $215 |
| Meloxicam Generic | 31 | 31 | Under 11 | $127 |
| Cyclobenzaprine Hcl Generic | 28 | 30 | Under 11 | $396 |
| Celecoxib Generic | 26 | 32 | 11 | $1,914 |
| Mycophenolate Mofetil Generic | 25 | 50 | Under 11 | $2,135 |
| Ibuprofen Generic | 21 | 25 | Under 11 | $387 |
| Levothyroxine Sodium Generic | 19 | 47 | Under 11 | $102 |
Brand drugs: - claims; generic drugs: 999 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ashley N Banayan $4,289 ($4,289 in general payments such as food, travel and fees) from 19 companies. The largest payer was Abbvie Inc. with $1,277.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 61 | $1,277 |
| UCB, Inc. UCB.BR | 36 | $1,020 |
| Amgen Inc. AMGN | 13 | $327 |
| Novartis Pharmaceuticals Corporation NVS | 20 | $291 |
| Pfizer Inc. PFE | 8 | $220 |
| AstraZeneca Pharmaceuticals LP AZN | 10 | $196 |
| GlaxoSmithKline, LLC. GSK | 8 | $179 |
| Janssen Biotech, Inc. JNJ | 8 | $168 |
| Alexion Pharmaceuticals, Inc. AZN | 6 | $150 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $98.5 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.